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Abstract
Rationale: Several lines of evidence suggest that cocaine expectancy and craving are two related
phenomena. The present study assessed this potential link by contrasting reactions to varying
degrees of the drug's perceived availability.
Method:  Non-treatment seeking individuals with cocaine dependence were administered an
intravenous bolus of cocaine (0.2 mg/kg) under 100% ('unblinded'; N = 33) and 33% ('blinded'; N =
12) probability conditions for the delivery of drug. Subjective ratings of craving, high, rush and low
along with heart rate and blood pressure measurements were collected at baseline and every
minute for 20 minutes following the infusions.
Results: Compared to the 'blinded' subjects, their 'unblinded' counterparts had similar craving
scores on a multidimensional assessment several hours before the infusion, but reported higher
craving levels on a more proximal evaluation, immediately prior to the receipt of cocaine.
Furthermore, the 'unblinded' subjects displayed a more rapid onset of high and rush cocaine
responses along with significantly higher cocaine-induced heart rate elevations.
Conclusion: These results support the hypothesis that cocaine expectancy modulates subjective
and objective responses to the drug. Provided the important public health policy implications of
heavy cocaine use, health policy makers and clinicians alike may favor cocaine craving assessments
performed in the settings with access to the drug rather than in more neutral environments as a
more meaningful marker of disease staging and assignment to the proper level of care.
1. Background
Cocaine dependence is a chronically relapsing disorder
leading to a variety of medical complications along with
devastating psychosocial consequences. It remains a
major public health problem bearing enormous societal
costs and is currently afflicting over 1.5 million American
citizens [1]. Thus, epidemiological data presented at the
recent Community Epidemiology Work Group meeting
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indicate that in a number of major US cities, representing
21 geographic areas, hospital admissions for primary
cocaine-related problems exceeded those for heroin,
methamphetamine and marihuana, altogether [2].
Craving, defined as an intense and often irrepressible urge
to seek and consume the drug, resulting in relapse even
after extended periods of abstinence [3], is one of the most
malignant and treatment resistant features of cocaine
dependence [4]. Therefore, in the search for innovative
and efficient therapeutic approaches, craving has been
subjected to an intensive scientific inquiry in both labora-
tory and clinical arenas. One consistent finding produced
by this effort, is a considerable overlap between neural
correlates of craving, cognition and motivation [3,5-7].
Hence, understanding how cocaine produces its effects
necessitates investigation of the cognitive and motiva-
tional contexts of craving.
Cocaine craving may result from the desire for pleasurable
effects of the drug [8]. A closely related concept to this
model is that of dopamine as the motivation/cognition-
related neurotransmitter, the phasic release of which
underlies the anticipation of pleasurable outcomes and
motivational behaviors targeted at avoiding the loss of
pleasure [9-16].
Primate electrophysiological studies of individual
dopamine neurons in the brain [9,17-21] have begun dis-
secting these motivational processes that could be poten-
tially broadened to cocaine craving. Neuronal responses
to reward and reward-predicating stimuli appear to be
dependent on event predictability i.e., neuronal activity is
increased by events with reward values which are better
than predicted, is uninfluenced by events that are as good
as predicted, and is reduced by events that are worse than
predicted [13,22,23]. Elevated dopamine concentrations
may also prime the organism to associate cues around
cocaine use with the pleasure experienced when drug is
taken [12,13,15,18-20,24]. When these cues are encoun-
tered again, they may elicit a surge of activity in dopamin-
ergic neurons leading to exaggerated anticipatory craving
of the future cocaine reward [25]. However, if individuals
with cocaine dependence are exposed to stimuli associ-
ated with cocaine when they cannot consume it, they may
experience a decrease in dopamine activity, which may
potentially lead to a dysphoric state of withdrawal [16].
These observations lead Volkow and colleagues [16] to
assume the existence of specific neural loci related to the
processes of expectancy, predictions of reward and contin-
gency assessment. They assessed this entity by using a two-
by-two within subjects design to measure the effects of
expectation on subjective effects and regional brain
metabolism in cocaine abusers under four conditions: 1)
expecting and receiving placebo; 2) expecting placebo and
receiving a drug similar to cocaine, methylphenidate; 3)
expecting methylphenidate and receiving placebo; 4)
expecting and receiving methylphenidate. The authors
found that expectation of the drug and subsequent receipt
of the drug led to an increased physiological response.
This was reflected in a 50% increase in global brain glu-
cose utilization, with specific increases in the thalamic
and cerebellar regions and an enhancement in subjective
assessments ("drug liking," "high," "feel drug," and "rest-
lessness") compared to expectation of placebo and receipt
of drug [16]. Thus, after methylphenidate infusion, the
presence or absence of the drug-induced subjective effects
apparently involved some retrieval and comparison to the
"remembered utility" [16], or the emotional memory
associated with the prior use.
The present study attempted to extend Volkow et al.'s [16]
findings to cocaine itself and to craving. To that end,
cocaine dependent subjects' self-reports of craving when
they were certain in the receipt of the drug were contrasted
to those when such probability stood at only 33%. The
primary hypothesis to be tested was that subjects experi-
ence stronger craving when they know that cocaine infu-
sion is forthcoming versus a situation in which it is less
likely. Other subjective ratings i.e., high, rush and low
[16,26] were assessed using exploratory analysis. Finally,
given the previous finding by our group that subjective
expectancy ratings accounted for some variance in the
hemodynamic responses to 'unblinded' cocaine [27], we
also examined the effects of perceived cocaine availability
on heart rate and on mean arterial pressure (MAP).
2. Methods
2.1 Participants
The study samples were comprised of non-treatment seek-
ing cocaine-dependent participants recruited by advertise-
ment who received cocaine under 'unblinded' (N = 33; 28
males and 5 females, 23 Caucasian and 10 African-Amer-
ican; mean age ± SD: 34.2 ± 6.0 years; weight: 77.0 ± 15.2
kg) and 'blinded' conditions (9 males and 3 females; 4
Caucasian and 8 African-American; mean age: 39.7 ± 7.8
years; weight: 79.9 ± 13.6 kg). The subjects were in good
physical health, not taking prescription medications or
other illegal drugs. All met DSM-IV criteria for cocaine
dependence with no past or current major depression or
other Axis I psychiatric diagnosis as assessed by the Struc-
tured Clinical Interview for DSM-IV Axis I Disorders
(SCID; [28]). Individuals using prescription medications
or those with dependence on other illegal drugs or alcohol
were excluded from study participation. 'Unblinded' and
'blinded' subjects' cocaine use averaged 13.2 ± 7.0 and 6.5
± 7.4 (t43 = 0.13, p = 0.9) times per month with the last
cocaine use 1.7 ± 1.2 and 1.4 ± 1.1 (t43 = 0.76, p = 0.45)
days prior to study participation, respectively, with smok-Substance Abuse Treatment, Prevention, and Policy 2007, 2:30 http://www.substanceabusepolicy.com/content/2/1/30
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ing being the primary route of cocaine ingestion. Subjects
provided written informed consent for the Massachusetts
General Hospital (MGH) Institutional Review Board-
approved protocol prior to initiating the study. The data
from these samples were previously reported [29-31] and
are included here for the purpose of contrasting the two
expectancy states (i.e., 'unblinded' vs. 'blinded').
2.2 Clinical protocol
Subjects were admitted to the MGH General Clinical
Research Center, having abstained from cocaine for at
least 10 hours and completed medical workup, including
urinalysis and breathalyzer tests for drug use, and struc-
tured clinical assessments including SCID [28], Addiction
Severity Index (ASI; [32]) and a multidimensional craving
questionnaire [33,34].
The latter assessment tool was demonstrated to be a relia-
ble predictor of short-, but not long-term cocaine use
[33,34] and it measures various aspects of craving on a
Likert-type scale (items rated on a scale of 0–9), including
(i) current intensity; (ii) desire to avoid using; (iii) capac-
ity to resist using; (iv) responsiveness to drug-related con-
ditioned stimuli; and (v) imagined likelihood of use if in
a setting with access to drugs. Subjects were assessed for
spontaneous craving after at least 10 hours abstinence
prior to administration of the infusions. Total spontane-
ous craving score was derived by adding together ratings
scores on items 1, 4 and 5 and subtracting items 2 and 3
[35]. The 'unblinded' and 'blinded' groups were compara-
ble in terms of their ASI drug composite scores (0.2 ± 0.1
and 0.2 ± 0.1; t43 = 0.2, p = 0.9) and the craving ratings the
total scores (17.6 ± 10.3 and 16.6 ± 10.5, respectively; t43
= 0.3, p = 0.8) on the multidimensional craving question-
naire.
For the 'unblinded' condition, the subjects were informed
that they would receive 0.2 mg/kg of cocaine, whereas the
'blinded' subjects were told they could receive any of three
infusions, namely cocaine 0.2 mg/kg, a low dose of hydro-
cortisone or a placebo and that each subsequent infusion
was non-contingent on the experience with the one pre-
ceding it.
Bilateral antecubital intravenous catheters were placed
(left forearm for infusions, right forearm for serial blood
sampling) and the infusion(s) was/were commenced after
a 60-minute rest period. Cocaine, hydrocortisone and
saline were administered as intravenous boluses in a vol-
ume of 10 mL, 2 hours apart in a double-blind, rand-
omized and counterbalanced cross-over design. Only
cocaine data are included in this report; hydrocortisone
and saline results are presented elsewhere [29-31]. Con-
tinuous hemodynamic monitoring was performed using
OmniTrak 3100 patient monitoring system (Orlando, FL)
and a board-certified cardiologist was present throughout
the whole study.
2.3 Subjective self-reports
The individualized description of subjective responses
were categorized into 4 components : craving, high, rush,
and low [36]. Cocaine craving was defined proactively
with each subject; clinically, as an urge to use the drug and
operationally, in terms of the action the individual would
be willing to engage in order to get more cocaine. The fol-
lowing were subjectively defined, but not necessarily asso-
ciated with a behavioral response or with the planning of
physical activity: high (well-being, self-confidence, and
sociability), rush (perception of elevated heart rate and
sweating, along with sensations of "speeding") and low
(dysphoric affect distinct from high experience diminish-
ment) [36]. Thus, of the four measures, only craving was
associated with a behavioral response or with planning or
implementation of physical activity. Therefore, by defini-
tion, only craving self-report could be defined as a moti-
vational state [36]. Behavioral ratings were acquired using
a Macintosh laptop placed on a table in front of the sub-
ject. The words "CRAVING", "HIGH", "RUSH" and
"LOW" appeared sequentially on the screen and with each
appearance the subject used the keyboard to rate them on
a continuous Likert-type scale of 0 (none) to 3 (extreme).
Ratings were initiated 2 minutes pre-infusion and a full set
was collected once per minute until 20 minutes post-infu-
sion.
2.4 Data analysis
Data were analyzed using SPSS 13.0 for Mac (SPSS, Inc.,
Chicago, IL). Baseline subjective scores were determined
from the mean of the self-reported ratings at 1- and 2-
minute time points prior to cocaine administration and
were compared using Student's t-test. When variances
were determined to be dissimilar, t-test corrected for sep-
arate variances was used. Repeated measures ANOVAs – 2
(group: 'unblinded' and 'blinded') × 20 (time: 20 min-
utes) were used to assess the subjective- and hemody-
namic variables. When violations of sphericity/
homogeneity assumptions were determined, a stringent
Greenhouse-Geisser (GG) correction was applied. In light
of previously reported cocaine's subjective effects in both
groups (Elman et al., 2002; Elman et al., 2003), a priori
emphasis was given to the group by time interaction effect
comparing responses of the 'unblinded' and 'blinded'
groups. Data were summarized as Mean ± standard devia-
tion. All analyses were two-tailed with α < 0.05 set as the
threshold for statistical significance.
3. Results
3.1 Covariation
Subjects' age was used as a covariate because participants
in the 'unblinded' group were younger (t43 = 2.47, p <Substance Abuse Treatment, Prevention, and Policy 2007, 2:30 http://www.substanceabusepolicy.com/content/2/1/30
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0.02) than in the 'blinded' group. To adjust for variability
in the baseline measures, subjective and hemodynamic
data were also (in addition to age) covaried for the pre-
infusion baseline values, as appropriate (e.g., baseline
craving reports for the craving data).
3.2 Subjective responses
Subjective data are graphically presented in Figure 1.
Despite similar craving scores on the multidimensional
craving questionnaire, pre-infusion craving ratings were
significantly higher (t43 = 2.05, corrected p < 0.009) in the
'unblinded' subjects, (0.67 ± 0.9), as compared to their
'blinded' counterparts (0.13 ± 0.4). In contrast, there were
no significant group differences in the pre-infusion high,
rush, or low ratings (p > 0.35).
For craving, repeated-measures ANOVA, covaried for the
baseline self-rating scores and age, revealed no effect of
group or group by time interaction (F1,41 = 1.8, p > 0.20),
indicating that following cocaine administration, both
groups' relative craving levels increased in a similar fash-
ion across the study time frame, with a main effect for
time (F19,760 = 3.21, GG adjusted p < 0.02).
For high, the group by time interaction was significant
(F19,760 = 2.09, p < 0.004), this effect, however, was not
sustained with the GG correction (adjusted p  = 0.06).
Rush ratings differences reached statistical significance
resulting in significant group by time interaction (F19,760 =
3.37, GG adjusted p < 0.004). Group differences in the
low ratings did not reach statistical significance (F19,760 =
0.55, GG adjusted p = 0.73).
3.3 Hemodynamic responses
Cocaine produced significantly higher heart rate increases
in the 'unblinded' subjects (Figure 2) (group effect: F1,41 =
7.26, p < 0.01; group-by-time interaction: F19,779 = 3.25,
GG adjusted p < 0.006; mean change from baseline: 30%
versus 20%). Changes in MAP were not apparent across
time by group (F19,779 = 1.63, GG adjusted p = 0.12).
4. Discussion
The major finding of this study is that changing the moti-
vational context from 100% to 33% cocaine expectancy,
by matching a potential cocaine infusion to two other
potential infusions, significantly modified subjective and
objective cocaine responses. To our knowledge, this is the
first report of a non-pharmacological effect of perceived
cocaine availability on self-reported baseline craving prior
to receiving cocaine and on subjective and hemodynamic
variables following cocaine administration.
The elevated high ratings in the 'unblinded' group,
although did not survive stringent statistical adjustment,
are suggestive of an expectancy component in cocaine's
rewarding effects and are consistent with the greater
"high" reports in the context of 100% vs. 50% methylphe-
nidate expectancy state [37]. Although there were impor-
tant methodological similarities between Volkow et al.
[37] and our study (i.e., enrollment of cocaine-dependent
subjects, use of subjective self-ratings and acute adminis-
tration of a psychostimulant), there were also substantial
differences in specific definitions of self-ratings, the prim-
ing agent, level of uncertainty about the receipt of the
Subjective responses Figure 1
Subjective responses. Effects of 'unblinded' vs. 'blinded' 
cocaine administration on craving, high rush and low ratings. 
Data are presented as mean (± SEM).
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drug, intersubject design, and the measures of hemody-
namic responses. Thus, these independent results strongly
support the validity of the relationship between expect-
ancy context and cocaine effects reflected in self-reports
and in physiological changes.
It is notable that notwithstanding similar (to the 'blinded'
group) craving scores on a multidimensional assessment
several hours before the infusions, 'unblinded' subjects
reported higher craving levels on a more proximal evalua-
tion, immediately prior to the infusions. These data are
consistent with a substantial body of literature [38-40]
documenting failure to detect a relationship between
measures of craving obtained in hospital and laboratory
environments (where expectancy of obtaining drugs is
low) and subsequent relapse to seeking and consuming
cocaine. Thus, this study suggests that even within a labo-
ratory environment, craving can be exacerbated by the
imminent availability of the drug. Furthermore, our data
may be indicative that the effect of expectancy is time sen-
sitive such that proximal rather than distant prospects of
getting the drug have greater effect on craving. Therefore,
in order to draw valid conclusions about clinical out-
comes, laboratory-based research may need to take into
account motivational and cognitive contexts of craving
e.g., perceived availability of the drug.
Probability of 100% for receipt of cocaine obviously
presents a stronger drug-related cue, as compared to 33%,
for the sensitized dopaminergic system, thus evoking
heightened anticipatory craving. This difference in craving
response levels off because the next cue i.e., the priming
dose of cocaine itself is not different between the groups.
Given the intuitively obvious liking of the desired objects
[41], subjects with elevated craving for cocaine, as those in
the 'unblinded' condition, presented heightened hedonic
rush responses. Alternatively, these may be reflective of
the hemodynamic effects (e.g., perception of the elevated
heart rate).
Subjective and hemodynamic cocaine effects may indeed
be connected via conditioned mechanisms. Thus, heart
rate elevations repeatedly paired with cocaine use may
become a conditioned stimulus and elicit cocaine-like
psychological responses [42,43], which in turn may pro-
duce increases in cardiovascular activity [44]. Such a self-
sustaining feed-forward loop whereby minor stimuli can
trigger escalating reactions may be implicated in both, the
chronically deteriorating course of cocaine dependence
[45] and in high rates of cardio- and cerebrovascular mor-
bidity associated with this illness [46]. Notably, that cau-
sality does not run in the opposite direction as
pharmacologically induced decrements in hemodynamic
indices do not seem to affect subjective effects of cocaine
[47,48].
Homeostatic regulation of hemodynamic function can be
dissected into distinct, but interacting catecholaminergic
systems including dopamine, norepinephrine and epine-
phrine. Dopamine has greater β than α affinity, which
explains its predominant heart rate effects. On the other
hand, a rather selective α agonist, norepinephrine, prima-
rily increases blood pressure, accompanied by only mini-
mal heart rate changes. Epinephrine binds both α and β
adrenoceptors, thus evenly affecting blood pressure and
heart rate [49]. Hence, different slopes of heart rate
increases in the 'unblinded' subjects may reflect an expect-
ancy-induced surge in dopamine [50,51], which is the key
neurochemical implicated in expectancy [13,19,20,52]
and in sensitization [53] effects.
An alternative/complimentary explanation may be con-
sistent with an idea that a psychological state, such as
cocaine expectancy, could alter the homeostatic barore-
flex, which is responsible for slowing the heart rate during
increases in blood pressure by relaying neural stimuli gen-
erated by the arterial receptors' distortion to the CNS,
nucleus of the solitary tract [49,54]. Future research can
evaluate signs of diminished baroreceptor function such
as orthostatic hypotension by performing supine and
upright blood pressure measurements along with Valsalva
maneuver and plasma catecholamine assays.
This study's strengths include fully randomized and coun-
terbalanced cocaine administration and employment of
both subjective and objective measures of cocaine
response. There are, however, some caveats that have to be
considered in interpreting the present data. First, a limita-
tion of the present study is that group differences in age
required us to perform statistical adjustments for this
potentially confounding variable. Second, the lack of true
randomization into the 'unblinded' and 'blinded' groups,
Heart rate Figure 2
Heart rate. Effects of 'unblinded' vs. 'blinded' cocaine 
administration on mean arterial pressure and heart rate. 
Data are presented as mean (± SEM).
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along with the modest size of the latter, render our results
preliminary pending replication in more rigorously
designed trials.
Third, although the crossover design in the 'blinded'
group offers certain advantages [55,56], a few effects
could have carried over from the hydrocortisone session.
This is unlikely, though, given only transient and subtle
subjective effects of hydrocortisone [34] and similar base-
line values of the reported variables (excluding craving).
Nonetheless, to fully account for such confounding, a sec-
ond placebo arm could be an important consideration for
future research. Fourth, mostly men participated in the
experiment and results may not be easily extrapolated to
women, as gender differences in craving have been previ-
ously demonstrated [57]. Finally, to accommodate for
motivational and attentional deficits commonly encoun-
tered in cocaine dependent populations [8,58-61], this
study focused on short-term acute subjective responses. As
some of the self-ratings did not return to baseline at the
conclusion of the 20-minute data collection period,
longer study duration may have yielded different results.
5. Conclusion
In conclusion, rather than being a unitary state character-
ized by one set of motivations [62], cocaine craving is
modulated by its own availability, which also affects other
emotions evoked by the drug and cocaine-induced hemo-
dynamic changes.
The inability to correlate craving and subsequent drug tak-
ing behavior, as has been shown for laboratory settings,
potentially generalizes to hospital and clinical treatment
facilities [34,63]. A better model could be evaluations per-
formed at a site with a greater likelihood of obtaining the
drug. Thus, current results suggest that more ecologically
valid assessments of craving, such as phone interviews in
a patient's home, might be important for understanding
the patterns of craving that lead to drug use and subse-
quently for intervention and prevention techniques as
well as for proper disease staging and treatment matching
procedures employed in public health policy research and
determination [64,65].
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